Selected article for: "coronavirus pneumonia diagnosis and pneumonia diagnosis"
Author: Chang Chen; Jianying Huang; Zhenshun Cheng; Jianyuan Wu; Song Chen; Yongxi Zhang; Bo Chen; Mengxin Lu; Yongwen Luo; Jingyi Zhang; Ping Yin; Xinghuan Wang
Title: Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial
  • Document date: 2020_3_20
    • ID: 14he8n3u_7
    Snippet: Patients were assessed for eligibility on the basis of: (1) aged 18 years or older; (2) voluntarily provided informed consent; (3) initial symptoms were within 12 days; (4) Diagnosed as COVID-19 pneumonia. According to the Chinese Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia at that moment, 10 severe or critical types of COVID-19 were eligible. Patients were excluded if they meet any of following criteria: (1) allergic to Favi.....
    Document: Patients were assessed for eligibility on the basis of: (1) aged 18 years or older; (2) voluntarily provided informed consent; (3) initial symptoms were within 12 days; (4) Diagnosed as COVID-19 pneumonia. According to the Chinese Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia at that moment, 10 severe or critical types of COVID-19 were eligible. Patients were excluded if they meet any of following criteria: (1) allergic to Favipiravir or Arbidol; (2) with elevated ALT/AST (>6x upper limit of normal range) or with chronic liver disease (cirrhosis at grade Child-Pugh C); (3) severe/critical patients whose expected survival time were <48 hours; (4) female in pregnancy; (5) HIV infection; or (6) considered unsuitable by researchers for the patient's best interest. Written informed consents were obtained from all patients or their authorized representatives if the patient was unable to write physically.

    Search related documents:
    Co phrase search for related documents
    • chronic liver disease and HIV infection: 1, 2, 3
    • chronic liver disease and informed consent: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • chronic liver disease and informed consent provide: 1
    • chronic liver disease and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
    • chronic liver disease and normal range: 1
    • chronic liver disease and survival time: 1
    • chronic liver disease and upper limit: 1, 2, 3, 4, 5, 6, 7, 8
    • critical severe type and liver disease: 1, 2, 3, 4
    • critical severe type and severe critical patient: 1
    • critical severe type and upper limit: 1
    • HIV infection and informed consent: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • HIV infection and informed consent provide: 1, 2
    • HIV infection and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • HIV infection and normal range: 1, 2, 3
    • HIV infection and pneumonia diagnose: 1
    • HIV infection and pregnancy female: 1
    • HIV infection and survival time: 1, 2, 3
    • HIV infection and upper limit: 1, 2, 3
    • informed consent and initial symptom: 1, 2